These drugs are FDA-approved for type 2 diabetes and obesity, but growing evidence supports their use for rheumatoid arthritis, psoriatic arthritis, lupus, osteoarthritis, and metabolic/autoimmune diseases. Who should not take GLP-1 medications
Bruises from previous injections Redness or ongoing irritation Scars or stretch marks Hard lumps from lipodystrophy Moles, birthmarks, or skin lesions Tattoos (the ink can make it harder to see reactions) Clean the injection site with an alcohol swab using a circular motion from the center outward
This hands-on approach allows him to identify how each patients body is responding and make timely adjustments to dosage or lifestyle recommendations when needed
Its essential to inform your healthcare provider about the incident, as they may need to adjust your dosage or investigate other potential causes
Supporting these pathways with supplemental B12 made theoretical sense as a way to optimize fat metabolism during tirzepatide therapy